We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Jul 2019 to Jul 2024
BUDAPEST--Hungarian oil and gas company MOL Nyrt. (MOL.BU), the country's largest refiner by market share, sold the company that owns the exploration license for the Surgut‐7 exploration block in Russia.
MAIN FACTS:
-MOL announced its plan to sell the block on 12 August 2013 in line with its portfolio optimization plans.
-The Surgut‐7 block is strongly linked to the infrastructure of the Zapadno‐Malobalykskoye field, which was until recently also a MOL asset. MOL sold these assets in a package deal, it said in a stock exchange filing.
-MOL closed trading up 1.9% or HUF295 at HUF16,195.
Write to the Budapest bureau at budapest@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
